505 related articles for article (PubMed ID: 16580974)
1. Integrating molecular design resources within modern drug discovery research: the Roche experience.
Stahl M; Guba W; Kansy M
Drug Discov Today; 2006 Apr; 11(7-8):326-33. PubMed ID: 16580974
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening in lead discovery and optimization.
Jain AN
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
[TBL] [Abstract][Full Text] [Related]
3. Structure-directed combinatorial library design.
Zhou JZ
Curr Opin Chem Biol; 2008 Jun; 12(3):379-85. PubMed ID: 18328830
[TBL] [Abstract][Full Text] [Related]
4. Synthetic library design.
Huwe CM
Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
[TBL] [Abstract][Full Text] [Related]
5. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in computer-aided drug design.
Song CM; Lim SJ; Tong JC
Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
[TBL] [Abstract][Full Text] [Related]
7. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
8. Recent trends in library design: 'rational design' revisited.
Schnur DM
Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
[TBL] [Abstract][Full Text] [Related]
9. Affinity-based screening techniques for enhancing lead discovery.
Comess KM; Schurdak ME
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics and cheminformatics: where do the twain meet?
Sukumar N; Krein M; Breneman CM
Curr Opin Drug Discov Devel; 2008 May; 11(3):311-9. PubMed ID: 18428084
[TBL] [Abstract][Full Text] [Related]
11. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
Rester U
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
[TBL] [Abstract][Full Text] [Related]
12. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
13. Chemogenomics: drug discovery's panacea?
Jacoby E
Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939
[TBL] [Abstract][Full Text] [Related]
14. Towards improving compound selection in structure-based virtual screening.
Waszkowycz B
Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
[TBL] [Abstract][Full Text] [Related]
15. Integrating virtual screening in lead discovery.
Oprea TI; Matter H
Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
[TBL] [Abstract][Full Text] [Related]
16. Exploring the chemogenomic knowledge space with annotated chemical libraries.
Savchuk NP; Balakin KV; Tkachenko SE
Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252
[TBL] [Abstract][Full Text] [Related]
17. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
Fischer HP; Heyse S
Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
[TBL] [Abstract][Full Text] [Related]
18. Systems biology in drug discovery.
Butcher EC; Berg EL; Kunkel EJ
Nat Biotechnol; 2004 Oct; 22(10):1253-9. PubMed ID: 15470465
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Structure-based approaches to antibiotic drug discovery.
Nicola G; Abagyan R
Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
